Archives

Gothenburg University, RISE and Iscaffpharma received the prestigious grant support and are partnering with AstraZeneca (LSE/STO/Nasdaq: AZN), for a project to develop synthetic 3D-models that [...]

Publication showing that cells cultured on patient-derived scaffolds closely resembled cells cultured on 3D printed scaffolds, contrasting 2D and Matrigel-cultured cells, regardless of a normoxic [...]

New publication showing how individual patient specific microenvironments influence the chemotherapy response in colorectal cancer. [...]

Published patent application for the use of patient derived scaffolds within immune-oncology The patent application covers the use of cell-free scaffolds  as a predictive tool in assessing cancer [...]

Breast Cancer Patient-Derived Scaffolds Can Expose Unique Individual Cancer Progressing Properties of the Cancer Microenvironment Associated with Clinical Characteristics [...]

Iscaffpharma interviewed on the importance of human microenvironment for pre-clinical drug screening. Listen here

8.-3d-printed-nanocellulose-scaffolds-as-a-cancer-cell-culture-model-system

7.-patientderived-scaffolds-as-a-drugtesting-platform-for-endocrine-therapies-in-breast-cancer

Alginate-based 3D printed scaffolds used as a model of patient derived breast cancer micro-environments in drug discovery. [...]

Article on patient derived scaffolds used for drug testing of Endocrinol treatments.